Poster presented at the International Society of Addiction Medicine Congress, Dundee, Scotland, October 5-8, 2015
Louise F. Haynes, MSW (Medical University of South Carolina, SC Node), Daniel J. Feaster, PhD (University of Miami Miller School of Medicine, FNA Node), Lisa R. Metsch, PhD (Columbia University, FNA Node).
In the United States, approximately one-third of HIV-infected persons either delay seeking care or do not seek care until their disease has progressed to require acute treatment. These patients may cycle through emergency rooms and hospital inpatient wards. The majority of these individuals are from communities of color that have traditionally been medically underserved; many of them are also either active or former substance users. Beginning in 2012, NIDA Clinical Trials Network's Project HOPE, a multi-site randomzied clinical trial designed to evaluate three strategies for linking and retaining HIV-infected substance users, recruited 801 participants from 11 hospital settings across the U.S. This poster describes the study rationale and inclusion criteria for Project HOPE, as well as the baseline drug use and demographic characteristics for the project, which describe a marginalized population with mutiple social and environmental problems. (Poster, PDF, English, 2015)
Keywords: HIV/AIDS | Minority populations | Retention | International Society of Addiction Medicine Congress, 2015
Document No: 1174.
Submitted by Louise F. Haynes, MSW, SC Node, 10/23/2015.